Connect Biopharma Holdings Ltd
Stock Chart, Company Information, and Scan Results
$2.66(as of Jul 9, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Connect Biopharma Holdings Ltd Company Information, Fundamentals, and Technical Indicators
Stock Price$2.66
Ticker SymbolCNTB
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees64
CountyUSA
Market Cap$139.2M
EBIDTA-65.5M
P/E Ratio-2.58
Forward P/E Ratio0.77
Earnings per Share-1.08
Profit Margin-11,478.11%
RSI64.70
Shares Outstanding63.0M
ATR0.21
52-Week High3.82
Volume2,463,774
52-Week Low1.11
Book Value42.6M
P/B Ratio3.91
Upper Keltner2.67
P/S Ratio669.93
Lower Keltner1.73
Next Earnings Date08/17/2026
Cash Surplus29.0M
Next Ex-Dividend DateUnknown
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Connect Biopharma Holdings Ltd In Our Stock Scanner
As of Jul 10, 2026
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.